Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
A Randomized Controlled Trial Comparing the Efficacy of Photobiomodulation Therapy and Alpha-Lipoic Acid in the Treatment of Burning Mouth Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study was to evaluate the efficacy of photobiomodulation therapy and alpha-lipoic acid in the treatment of burning mouth syndrome by symptom assessment with visual analogue scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2026
CompletedFirst Submitted
Initial submission to the registry
January 25, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedFebruary 3, 2026
January 1, 2026
10 months
January 25, 2026
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
The Visual Analogue Scale (VAS) will be used to assess the intensity of the patient's pain. The scale ranges from 0 to 10, where 0 represents "no pain" (the best possible outcome) and 10 represents "the worst pain imaginable" (the worst possible outcome). Therefore, higher scores indicate a worse outcome (greater pain intensity). During the interview or telephone follow-up, the patient will be asked to report the number that best describes their pain.
Baseline and 2 weeks after intervention or observation
Study Arms (2)
PBMT group
EXPERIMENTALBurning mouth syndrome (BMS) patients in PBMT group were provided with BMS disease explanation and psychological counseling. They will receive low-energy laser therapy with an energy density of 5 J/cm² and a power of 0.1/0.5 W for a consecutive period of 2 weeks, 5 days per week.
ALA group
ACTIVE COMPARATORBurning mouth syndrome (BMS) patients in the ALA group were provided with BMS disease explanation and psychological counseling. Then they took α-lipoic acid (ALA) 3 times a day, after meals, 200 mg each time, for 2 consecutive weeks.
Interventions
Energy density: 5 J/cm² Power: 0.1/0.5 W Course of treatment: 2 consecutive weeks, 5 days per week.
Dosage: 600-800 mg ALA Course of treatment: 2 consecutive weeks, 3 times per day
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 75 years
- Diagnosis of Burning Mouth Syndrome (BMS) according to the 3rd edition of the International Classification of Headache Disorders (ICHD-3)
- Daily intraoral burning or dysesthesia lasting for more than 2 hours for over 3 months
- Normal oral mucosa and sensory testing
- Condition not better accounted for by another ICHD-3 diagnosis
You may not qualify if:
- Other oral mucosal diseases, such as oral leukoplakia or oral lichen planus
- Diabetes with poor blood glucose control
- Hematological diseases
- Pregnancy or lactation
- Severe mental disorders preventing cooperation with treatment
- Heart failure (New York Heart Association class III-IV)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lu Jianglead
Study Sites (1)
West China Hospital of Stomatology, Sichuan University
Chengdu, Sichuan, 610041, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lu Jiang, MD
Sichuan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 2, 2026
Study Start
April 10, 2025
Primary Completion
January 20, 2026
Study Completion
March 10, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share